Cargando…
Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke
Background: Astrogliosis has the potential to lead to harmful effects, namely, neuroinflammation, and to interfere with synapse sprouting. Previous studies have suggested that Lipocalin-2 (LCN2) acts as a key target in regulating the reaction of astrocytes. However, the underlying molecular mechanis...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964562/ https://www.ncbi.nlm.nih.gov/pubmed/29867513 http://dx.doi.org/10.3389/fphar.2018.00518 |
_version_ | 1783325201744789504 |
---|---|
author | Zhang, Yehao Liu, Jianxun Yang, Bin Zheng, Yongqiu Yao, Mingjiang Sun, Mingqian Xu, Li Lin, Chengren Chang, Dennis Tian, Fangze |
author_facet | Zhang, Yehao Liu, Jianxun Yang, Bin Zheng, Yongqiu Yao, Mingjiang Sun, Mingqian Xu, Li Lin, Chengren Chang, Dennis Tian, Fangze |
author_sort | Zhang, Yehao |
collection | PubMed |
description | Background: Astrogliosis has the potential to lead to harmful effects, namely, neuroinflammation, and to interfere with synapse sprouting. Previous studies have suggested that Lipocalin-2 (LCN2) acts as a key target in regulating the reaction of astrocytes. However, the underlying molecular mechanism is not fully elucidated. In the present study, we examined the neuroprotective and anti-inflammatory effects of Ginkgo biloba extract (EGB), a well-known extract with potential immunoregulatory properties in the nervous system. Methods: Triphenyltetrazolium chloride staining, hematoxylin-eosin staining, electron microscopy, and neurological assessments were performed in a microsphere-embolized rat model. Human astrocytes exposed to oxygen glucose deprivation (OGD) were used for in vitro experiments. Inflammatory cytokines, multi-labeling immunofluorescence, and Western blotting were used to investigate the molecular mechanisms underlying the EGB-mediated anti-inflammatory effects in vivo and in vitro. Results: EGB markedly attenuated cerebral infarction and neuronal apoptosis, reduced the inflammatory cytokine level, and alleviated neurological deficiencies in cerebral ischemic rats. After surgery, EGB significantly inhibited astrocyte activation, reduced the phosphorylation of STAT3 and JAK2 and decreased LCN2 expression. In vitro, EGB blocked OGD-induced STAT3 activation and the generation of pro-inflammatory cytokines in human astrocytes, and these effects were significantly enhanced by LCN2 overexpression. EGB downregulated these effects enhanced by LCN2 overexpression. Conclusion: EGB is demonstrated to mediate neuroinflammation, which protects against ischemic brain injury by inhibiting astrogliosis and suppresses neuroinflammation via the LCN2-JAK2/STAT3 pathway, providing insight into a promising therapeutic strategy for ischemic stroke. |
format | Online Article Text |
id | pubmed-5964562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59645622018-06-04 Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke Zhang, Yehao Liu, Jianxun Yang, Bin Zheng, Yongqiu Yao, Mingjiang Sun, Mingqian Xu, Li Lin, Chengren Chang, Dennis Tian, Fangze Front Pharmacol Pharmacology Background: Astrogliosis has the potential to lead to harmful effects, namely, neuroinflammation, and to interfere with synapse sprouting. Previous studies have suggested that Lipocalin-2 (LCN2) acts as a key target in regulating the reaction of astrocytes. However, the underlying molecular mechanism is not fully elucidated. In the present study, we examined the neuroprotective and anti-inflammatory effects of Ginkgo biloba extract (EGB), a well-known extract with potential immunoregulatory properties in the nervous system. Methods: Triphenyltetrazolium chloride staining, hematoxylin-eosin staining, electron microscopy, and neurological assessments were performed in a microsphere-embolized rat model. Human astrocytes exposed to oxygen glucose deprivation (OGD) were used for in vitro experiments. Inflammatory cytokines, multi-labeling immunofluorescence, and Western blotting were used to investigate the molecular mechanisms underlying the EGB-mediated anti-inflammatory effects in vivo and in vitro. Results: EGB markedly attenuated cerebral infarction and neuronal apoptosis, reduced the inflammatory cytokine level, and alleviated neurological deficiencies in cerebral ischemic rats. After surgery, EGB significantly inhibited astrocyte activation, reduced the phosphorylation of STAT3 and JAK2 and decreased LCN2 expression. In vitro, EGB blocked OGD-induced STAT3 activation and the generation of pro-inflammatory cytokines in human astrocytes, and these effects were significantly enhanced by LCN2 overexpression. EGB downregulated these effects enhanced by LCN2 overexpression. Conclusion: EGB is demonstrated to mediate neuroinflammation, which protects against ischemic brain injury by inhibiting astrogliosis and suppresses neuroinflammation via the LCN2-JAK2/STAT3 pathway, providing insight into a promising therapeutic strategy for ischemic stroke. Frontiers Media S.A. 2018-05-16 /pmc/articles/PMC5964562/ /pubmed/29867513 http://dx.doi.org/10.3389/fphar.2018.00518 Text en Copyright © 2018 Zhang, Liu, Yang, Zheng, Yao, Sun, Xu, Lin, Chang and Tian. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhang, Yehao Liu, Jianxun Yang, Bin Zheng, Yongqiu Yao, Mingjiang Sun, Mingqian Xu, Li Lin, Chengren Chang, Dennis Tian, Fangze Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke |
title | Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke |
title_full | Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke |
title_fullStr | Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke |
title_full_unstemmed | Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke |
title_short | Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke |
title_sort | ginkgo biloba extract inhibits astrocytic lipocalin-2 expression and alleviates neuroinflammatory injury via the jak2/stat3 pathway after ischemic brain stroke |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964562/ https://www.ncbi.nlm.nih.gov/pubmed/29867513 http://dx.doi.org/10.3389/fphar.2018.00518 |
work_keys_str_mv | AT zhangyehao ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT liujianxun ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT yangbin ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT zhengyongqiu ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT yaomingjiang ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT sunmingqian ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT xuli ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT linchengren ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT changdennis ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke AT tianfangze ginkgobilobaextractinhibitsastrocyticlipocalin2expressionandalleviatesneuroinflammatoryinjuryviathejak2stat3pathwayafterischemicbrainstroke |